Mir31 (microRNA 31) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Mir31 (microRNA 31) Rattus norvegicus
Analyze
Symbol: Mir31
Name: microRNA 31
RGD ID: 2325391
Description: Predicted to enable mRNA 3'-UTR binding activity; mRNA CDS binding activity; and mRNA base-pairing translational repressor activity. Involved in negative regulation of epithelial to mesenchymal transition; positive regulation of mesenchymal cell proliferation; and response to zinc ion. Predicted to be located in extracellular space and microvesicle. Predicted to be part of RISC complex. Used to study esophagus squamous cell carcinoma. Biomarker of hepatocellular carcinoma. Human ortholog(s) of this gene implicated in colorectal cancer and nasopharynx carcinoma. Orthologous to human MIR31 (microRNA 31); INTERACTS WITH 2-acetamidofluorene; 3,7-dihydropurine-6-thione; aflatoxin B1.
Type: ncrna
RefSeq Status: PROVISIONAL
Previously known as: Mir31a; rno-mir-31; rno-mir-31a
RGD Orthologs
Human
Mouse
Dog
Pig
Alliance Orthologs
More Info more info ...
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr85108,714,849 - 108,714,954 (-)NCBIGRCr8
mRatBN7.25103,599,038 - 103,599,143 (-)NCBImRatBN7.2mRatBN7.2
UTH_Rnor_SHR_Utx5106,031,567 - 106,031,672 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.05107,761,170 - 107,761,275 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.05107,834,100 - 107,834,205 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.05107,206,515 - 107,206,620 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.05111,183,081 - 111,183,186 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera5102,327,983 - 102,328,088 (-)NCBICelera
Cytogenetic Map5q32NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


1 to 20 of 41 rows

  
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31Ratbile duct cancer exacerbatesISORGD:1343532152998990RNA:increased expression:bile duct (human)RGD 
Mir31Ratbreast cancer  ISORGD:1343532153297766RNA:decreased expression:peripheral blood mononuclear cell (human)RGD 
Mir31Ratcervical squamous cell carcinoma  ISORGD:1343532152998938RNA:increased expression:blood serum (human)RGD 
Mir31RatColitis-Associated Neoplasms exacerbatesISORGD:1608161152998983 RGD 
Mir31RatColonic Neoplasms  ISORGD:13435329068941associated with inflammatory bowel disease; RNA:increased expression:colorectal mucosa (human)RGDPMID:20848542|REF_RGD_ID:153297753
Mir31Ratcolorectal adenocarcinoma  ISORGD:1343532152998938RNA:increased expression:blood serum (human)RGD 
Mir31Ratcolorectal cancer  ISORGD:1343532153002793miRNA:increased expression:colorectum (human)RGD 
Mir31Ratcolorectal cancer disease_progressionISORGD:1343532153297791RNA:increased expression:colorectum (human)RGD 
Mir31Ratcolorectal cancer  ISORGD:134353211530687RNA:increased expression:colorectal mucosa (human)RGD 
Mir31Ratcolorectal cancer treatmentISORGD:1343532153297782human cells in mouse modelRGD 
Mir31Ratcolorectal cancer disease_progressionISORGD:1343532152998983RNA:increased expression:colorectum (human)RGD 
Mir31Ratcolorectal cancer  ISORGD:1343532153297812RNA:increased expression:colorectum (human)RGD 
Mir31Ratcolorectal cancer exacerbatesISORGD:1343532153297808miRNA:increased expression:colorectal mucosa (human)RGD 
Mir31Ratesophagus squamous cell carcinoma amelioratesIMP 127285381 RGD 
Mir31Ratesophagus squamous cell carcinoma amelioratesISORGD:1343532152998938 RGD 
Mir31Ratgastric adenocarcinoma  ISORGD:1343532152998938RNA:decreased expression:blood serum (human)RGD 
Mir31Ratglioblastoma  ISORGD:1343532152998941RNA:decreased expression:brain (human)RGD 
Mir31Rathepatocellular carcinoma severityISORGD:134353211085965miRNA:decreased expression:liver (human)RGD 
Mir31Rathepatocellular carcinoma  ISORGD:1343532152998991RNA:decreased expression:liver (human)RGD 
Mir31Rathepatocellular carcinoma  IEP 11085965miRNA:decreased expression:liver (rat)RGD 
1 to 20 of 41 rows
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31Ratschizophrenia  ISORGD:13435328554872ClinVar Annotator: match by term: SchizophreniaClinVarPMID:21681106|PMID:30208311
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31RatLung Neoplasms  ISORGD:134353211554173CTD Direct Evidence: marker/mechanismCTDPMID:20237410
Mir31RatNeoplasm Metastasis  ISORGD:134353211554173CTD Direct Evidence: marker/mechanismCTDPMID:19487542
Mir31Ratpancreatitis  ISORGD:134353211554173CTD Direct Evidence: marker/mechanismCTDPMID:27840954

1 to 20 of 48 rows

  
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31Rat1,2-dichloroethane decreases expressionISORGD:16081616480464ethylene dichloride results in decreased expression of MIR31 mRNACTDPMID:28960355
Mir31Rat2,3,7,8-tetrachlorodibenzodioxine increases expressionISORGD:16081616480464Tetrachlorodibenzodioxin results in increased expression of MIR31 mRNACTDPMID:37318321
Mir31Rat2-acetamidofluorene increases expressionEXP 64804642-Acetylaminofluorene results in increased expression of MIR31; 2-Acetylaminofluorene results in increased expression of MIR31 mRNACTDPMID:19167416|PMID:20188851
Mir31Rat2-hydroxypropanoic acid increases expressionISORGD:13435326480464Lactic Acid results in increased expression of MIR31 mRNACTDPMID:30851411
Mir31Rat3,7-dihydropurine-6-thione increases expressionEXP 6480464Mercaptopurine results in increased expression of MIR31 mRNACTDPMID:23358152
Mir31Rat3-chloropropane-1,2-diol increases expressionISORGD:16081616480464alpha-Chlorohydrin analog results in increased expression of MIR31 mRNACTDPMID:29860048
Mir31Rataflatoxin B1 decreases expressionEXP 6480464Aflatoxin B1 results in decreased expression of MIR31 mRNACTDPMID:24472605
Mir31Ratantigen increases expressionISORGD:16081616480464Antigens results in increased expression of MIR31 mRNACTDPMID:27038180
Mir31RatAroclor 1254 increases expressionISORGD:13435326480464Chlorodiphenyl (54% Chlorine) results in increased expression of MIR31 mRNACTDPMID:27481218
Mir31Ratarsenite(3-) increases expressionISORGD:13435326480464arsenite results in increased expression of MIR31 mRNACTDPMID:22728250
Mir31Ratatrazine decreases expressionEXP 6480464Atrazine results in decreased expression of MIR31 mRNACTDPMID:31185338|PMID:36841081
Mir31Ratbis(2-chloroethyl) sulfide decreases expressionISORGD:16081616480464Mustard Gas results in decreased expression of MIR31 mRNACTDPMID:26456178
Mir31Ratbis(2-ethylhexyl) phthalate decreases expressionEXP 6480464Diethylhexyl Phthalate results in decreased expression of MIR31 mRNACTDPMID:28192093
Mir31Ratbis(2-ethylhexyl) phthalate decreases expressionISORGD:16081616480464Diethylhexyl Phthalate results in decreased expression of MIR31CTDPMID:32642447
Mir31Ratbis(2-ethylhexyl) phthalate decreases expressionISORGD:13435326480464Diethylhexyl Phthalate results in decreased expression of MIR31CTDPMID:33229049
Mir31Ratbleomycin A2 decreases expressionEXP 6480464Bleomycin results in decreased expression of MIR31 mRNACTDPMID:25933445
Mir31Ratcatechol increases expressionISORGD:16081616480464catechol results in increased expression of MIR31 mRNACTDPMID:32105654
Mir31Ratcholine multiple interactionsISORGD:16081616480464[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ...CTDPMID:20548288
Mir31Ratcisplatin increases expressionEXP 6480464Cisplatin results in increased expression of MIR31 mRNACTDPMID:24880025
Mir31Ratcisplatin increases expressionISORGD:16081616480464Cisplatin results in increased expression of MIR31 mRNACTDPMID:28119452

1 to 20 of 48 rows

Biological Process
1 to 20 of 20 rows

  
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31Ratcellular response to amino acid stimulus acts_upstream_of_or_withinISORGD:16081611624291 PMID:20548288RGDPMID:20548288
Mir31Ratcellular response to decreased oxygen levels acts_upstream_of_or_withinISORGD:16081611624291 PMID:19147652RGDPMID:19147652
Mir31Ratcellular response to tumor necrosis factor involved_inISORGD:13435321624291 PMID:19949084RGDPMID:19949084
Mir31RatmiRNA-mediated gene silencing by inhibition of translation involved_inISORGD:13435321624291 PMID:20826792, PMID:27225184RGDPMID:20826792|PMID:27225184
Mir31RatmiRNA-mediated post-transcriptional gene silencing involved_inISORGD:13435321624291 PMID:19949084, PMID:22948084, PMID:24558106, PMID:26933040, PMID:27225184, PMID:28097093, PMID:30683932, PMID:31012336, PMID:32069773, PMID:32561494RGDPMID:19949084|PMID:22948084|PMID:24558106|PMID:26933040|PMID:27225184|PMID:28097093|PMID:30683932|PMID:31012336|PMID:32069773|PMID:32561494
Mir31Ratnegative regulation of amyloid fibril formation acts_upstream_ofISORGD:13435321624291UniProtKB:P05067 PMID:32069773RGDPMID:32069773
Mir31Ratnegative regulation of amyloid precursor protein biosynthetic process involved_inISORGD:13435321624291UniProtKB:P05067 PMID:32069773RGDPMID:32069773
Mir31Ratnegative regulation of cell migration involved_inISORGD:13435321624291 PMID:22948084RGDPMID:22948084
Mir31Ratnegative regulation of epithelial to mesenchymal transition  IMP 13210526 RGD 
Mir31Ratnegative regulation of interleukin-34 production involved_inISORGD:13435321624291 PMID:31012336RGDPMID:31012336
Mir31Ratnegative regulation of leukocyte adhesion to vascular endothelial cell involved_inISORGD:13435321624291 PMID:19949084RGDPMID:19949084
Mir31Ratossification acts_upstream_of_or_withinISORGD:16081611624291 PMID:25751060RGDPMID:25751060
Mir31Ratpositive regulation of angiogenesis involved_inISORGD:13435321624291 PMID:28097093RGDPMID:28097093
Mir31Ratpositive regulation of blood vessel endothelial cell migration involved_inISORGD:13435321624291 PMID:26933040RGDPMID:26933040
Mir31Ratpositive regulation of cell migration involved in sprouting angiogenesis involved_inISORGD:13435321624291 PMID:24558106RGDPMID:24558106
Mir31Ratpositive regulation of mesenchymal cell proliferation  IMP 13210526 RGD 
Mir31Ratpositive regulation of sprouting angiogenesis involved_inISORGD:13435321624291 PMID:26933040RGDPMID:26933040
Mir31Ratresponse to nitrogen compound  IEP 11085965 RGD 
Mir31Ratresponse to zinc ion  IEP 127285381 RGD 
Mir31Ratsensory perception of sound acts_upstream_of_or_withinISORGD:16081611624291 PMID:23646144RGDPMID:23646144
1 to 20 of 20 rows

Cellular Component

  
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31Ratextracellular space located_inISORGD:13435321624291 PMID:24558106RGDPMID:24558106
Mir31Ratmicrovesicle located_inISORGD:13435321624291 PMID:26933040RGDPMID:26933040
Mir31RatRISC complex part_ofISORGD:13435321624291UniProtKB:Q9UKV8 PMID:31012336RGDPMID:31012336

Molecular Function

  
Object Symbol
Species
Term
Qualifier
Evidence
With
Reference
Notes
Source
Original Reference(s)
Mir31RatmRNA 3'-UTR binding enablesISORGD:13435321624291 PMID:22948084, PMID:32069773RGDPMID:22948084|PMID:32069773
Mir31RatmRNA base-pairing post-transcriptional repressor activity enablesISORGD:13435321624291 PMID:19949084, PMID:20826792, PMID:22948084, PMID:24558106, PMID:26933040, PMID:27225184, PMID:28097093, PMID:30683932, PMID:31012336, PMID:32069773, PMID:32561494RGDPMID:19949084|PMID:20826792|PMID:22948084|PMID:24558106|PMID:26933040|PMID:27225184|PMID:28097093|PMID:30683932|PMID:31012336|PMID:32069773|PMID:32561494
Mir31RatmRNA CDS binding enablesISORGD:13435321624291 PMID:32069773RGDPMID:32069773
Mir31Ratprotein binding enablesISORGD:13435321624291UniProtKB:Q9UKV8 PMID:31012336RGDPMID:31012336


1 to 20 of 34 rows
#
Reference Title
Reference Citation
1. Islet-1 is a dual regulator of fibrogenic epithelial-to-mesenchymal transition in epicardial mesothelial cells. Brønnum H, etal., Exp Cell Res. 2013 Feb 15;319(4):424-35. doi: 10.1016/j.yexcr.2012.12.019. Epub 2012 Dec 24.
2. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA. Chen Z, etal., Med Sci Monit. 2016 Dec 1;22:4679-4691. doi: 10.12659/msm.898399.
3. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Cheung CC, etal., Mol Cancer. 2014 Aug 7;13:184. doi: 10.1186/1476-4598-13-184.
4. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer. Du YL, etal., Exp Cell Res. 2020 Oct 1;395(1):112176. doi: 10.1016/j.yexcr.2020.112176. Epub 2020 Jul 16.
5. MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. Edmonds MD, etal., J Clin Invest. 2016 Jan;126(1):349-64. doi: 10.1172/JCI82720. Epub 2015 Dec 14.
6. Abrogation of esophageal carcinoma development in miR-31 knockout rats. Fong LY, etal., Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6075-6085. doi: 10.1073/pnas.1920333117. Epub 2020 Mar 2.
7. MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1. Gwiggner M, etal., Genes (Basel). 2018 Feb 13;9(2). pii: genes9020085. doi: 10.3390/genes9020085.
8. Human miR-31 targets radixin and inhibits migration and invasion of glioma cells. Hua D, etal., Oncol Rep. 2012 Mar;27(3):700-6. doi: 10.3892/or.2011.1555. Epub 2011 Nov 15.
9. MicroRNA-31 reflects IL-6 expression in cancer tissue and is related with poor prognosis in bile duct cancer. Ishigami K, etal., Carcinogenesis. 2018 Sep 21;39(9):1127-1134. doi: 10.1093/carcin/bgy075.
10. MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer. Kim HS, etal., Oncotarget. 2015 Apr 10;6(10):8089-102.
11. Associations Between miRNAs and Two Different Cancers: Breast and Colon. Kundaktepe BP, etal., Cancer Manag Res. 2020 Feb 7;12:871-879. doi: 10.2147/CMAR.S227628. eCollection 2020.
12. Validation of miR-31-3p Expression to Predict Cetuximab Efficacy When Used as First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer. Laurent-Puig P, etal., Clin Cancer Res. 2019 Jan 1;25(1):134-141. doi: 10.1158/1078-0432.CCR-18-1324. Epub 2018 Aug 14.
13. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1). Li Y, etal., Biomed Pharmacother. 2019 Mar;111:517-526. doi: 10.1016/j.biopha.2018.12.102. Epub 2018 Dec 28.
14. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer. Liu CJ, etal., Oral Dis. 2010 May;16(4):360-4. doi: 10.1111/j.1601-0825.2009.01646.x. Epub 2010 Mar 9.
15. Conditional knockout of microRNA-31 promotes the development of colitis associated cancer. Liu Z, etal., Biochem Biophys Res Commun. 2017 Aug 12;490(1):62-68. doi: 10.1016/j.bbrc.2017.06.012. Epub 2017 Jun 6.
16. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Meng W, etal., Clin Cancer Res. 2013 Oct 1;19(19):5423-33. doi: 10.1158/1078-0432.CCR-13-0320. Epub 2013 Aug 14.
17. MiR-31-5p promotes the cell growth, migration and invasion of colorectal cancer cells by targeting NUMB. Peng H, etal., Biomed Pharmacother. 2019 Jan;109:208-216. doi: 10.1016/j.biopha.2018.10.048. Epub 2018 Nov 2.
18. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma. Qin J, etal., Biomed Pharmacother. 2018 Mar;99:363-368. doi: 10.1016/j.biopha.2018.01.037.
19. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
20. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection. Su Y, etal., Clin Epigenetics. 2016 Oct 19;8:109. doi: 10.1186/s13148-016-0275-5. eCollection 2016.
1 to 20 of 34 rows
PMID:16381832   PMID:17604727   PMID:19147652   PMID:20403161   PMID:20548288   PMID:21993888   PMID:22020941   PMID:23517179   PMID:23646144   PMID:25168901   PMID:25728779   PMID:25751060  
PMID:28865712   PMID:29053138   PMID:29286111   PMID:29620173   PMID:32135167   PMID:33015806   PMID:38816686   PMID:38894694  



Mir31
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr85108,714,849 - 108,714,954 (-)NCBIGRCr8
mRatBN7.25103,599,038 - 103,599,143 (-)NCBImRatBN7.2mRatBN7.2
UTH_Rnor_SHR_Utx5106,031,567 - 106,031,672 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.05107,761,170 - 107,761,275 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.05107,834,100 - 107,834,205 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.05107,206,515 - 107,206,620 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.05111,183,081 - 111,183,186 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera5102,327,983 - 102,328,088 (-)NCBICelera
Cytogenetic Map5q32NCBI
MIR31
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38921,512,115 - 21,512,185 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl921,512,115 - 21,512,185 (-)EnsemblGRCh38hg38GRCh38
GRCh37921,512,114 - 21,512,184 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36921,502,113 - 21,502,183 (-)NCBINCBI36Build 36hg18NCBI36
Celera921,450,429 - 21,450,499 (-)NCBICelera
Cytogenetic Map9p21.3NCBI
HuRef921,475,518 - 21,475,588 (-)NCBIHuRef
CHM1_1921,511,915 - 21,511,985 (-)NCBICHM1_1
T2T-CHM13v2.0921,526,301 - 21,526,371 (-)NCBIT2T-CHM13v2.0
Mir31
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39488,828,794 - 88,828,899 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl488,828,794 - 88,828,899 (-)EnsemblGRCm39 Ensembl
GRCm38488,910,557 - 88,910,662 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl488,910,557 - 88,910,662 (-)EnsemblGRCm38mm10GRCm38
MGSCv37488,556,461 - 88,556,566 (-)NCBIGRCm37MGSCv37mm9NCBIm37
Celera487,392,515 - 87,392,620 (-)NCBICelera
Cytogenetic Map4C4NCBI
cM Map442.05NCBI
MIR31
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.11140,904,438 - 40,904,496 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1140,904,437 - 40,904,503 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1139,576,885 - 39,576,943 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01141,846,612 - 41,846,670 (-)NCBIROS_Cfam_1.0
UMICH_Zoey_3.11140,518,076 - 40,518,134 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01140,405,265 - 40,405,323 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01141,018,979 - 41,019,037 (-)NCBIUU_Cfam_GSD_1.0
MIR31
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1201,198,732 - 201,198,809 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11201,198,732 - 201,198,809 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21224,397,161 - 224,397,238 (+)NCBISscrofa10.2Sscrofa10.2susScr3

.

Confirmed Targets
Gene TargetMature miRNAMethod NameResult TypeData TypeSupport TypePMID
Isl1rno-miR-31a-5pMirtarbaseexternal_infoImmunofluorescence//Luciferase reporter assayFunctional MTI23270756
Klf5rno-miR-31a-5pMirtarbaseexternal_infoReporter assayFunctional MTI19542014

Predicted Targets
Summary Value
Count of predictions:8927
Count of gene targets:5579
Count of transcripts:5975
Interacting mature miRNAs:rno-miR-31a-3p, rno-miR-31a-5p
Prediction methods:Microtar, Miranda, Pita, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


1 to 10 of 43 rows
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD ID
Symbol
Name
LOD
P Value
Trait
Sub Trait
Chr
Start
Stop
Species
1357396Bw44Body weight QTL 444.19body mass (VT:0001259)body weight (CMO:0000012)568984307104251008Rat
1331796Thshl2Thyroid stimulating hormone level QTL 22.3blood thyroid-stimulating hormone amount (VT:0005119)serum thyroid stimulating hormone level (CMO:0001248)597059760147465714Rat
1549845Scl44Serum cholesterol level QTL 446blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)540128307148607290Rat
61380Edpm5Estrogen-dependent pituitary mass QTL 54.50.92pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)568984307104251008Rat
70212Niddm25Non-insulin dependent diabetes mellitus QTL 253.54blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)51131345958Rat
1298070Scl18Serum cholesterol level QTL 183.7blood LDL cholesterol amount (VT:0000181)calculated plasma low density lipoprotein cholesterol level (CMO:0001245)579584860124584860Rat
634305Mamtr1Mammary tumor resistance QTL 10.0001mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)512789751113558310Rat
61452Ciaa5CIA Autoantibody QTL 53.5blood autoantibody amount (VT:0003725)calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281)594858972143070159Rat
1331801Rf33Renal function QTL 334.149kidney blood vessel physiology trait (VT:0100012)absolute change in renal vascular resistance (CMO:0001900)543726656129132602Rat
1357402Bw46Body weight QTL 464.47body mass (VT:0001259)body mass index (BMI) (CMO:0000105)568984307104251008Rat

1 to 10 of 43 rows





RefSeq Transcripts NR_031845 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide JAXUCZ010000005 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

RefSeq Acc Id: NR_031845
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr85108,714,849 - 108,714,954 (-)NCBI
mRatBN7.25103,599,038 - 103,599,143 (-)NCBI
Rnor_6.05107,206,515 - 107,206,620 (+)NCBI
Rnor_5.05111,183,081 - 111,183,186 (+)NCBI
Celera5102,327,983 - 102,328,088 (-)NCBI
Sequence:


Database
Acc Id
Source(s)
BioCyc Gene G2FUF-40790 BioCyc
miRBase MI0000872 ENTREZGENE
NCBI Gene 100314232 ENTREZGENE
PhenoGen Mir31 PhenoGen
RNAcentral URS00000DE5AF RNACentral
  URS00002B9AD0 RNACentral
  URS000075D93C RNACentral


Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2015-04-09 Mir31  microRNA 31  Mir31  microRNA mir-31  Name updated 61478 APPROVED
2010-06-02 Mir31  microRNA mir-31      Symbol and Name status set to provisional 70820 PROVISIONAL